Found 6 hits for monomerid = 50191163 Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
Cytochrome P450 2C19
(Homo sapiens (Human)) | BDBM50191163
![PNG](/data/jpeg/tenK5019/BindingDB_50191163.png) (1-(2-(benzyloxy)-5-bromobenzyl)-5-methyl-1H-pyrazo...)Show InChI InChI=1S/C19H17BrN2O3/c1-13-9-17(19(23)24)21-22(13)11-15-10-16(20)7-8-18(15)25-12-14-5-3-2-4-6-14/h2-10H,11-12H2,1H3,(H,23,24) | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet ![](/images/AffyNet_logo.png)
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| n/a | n/a | >1.00E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
GlaxoSmithKline
Curated by ChEMBL
| Assay Description Inhibition of CYP450 2C19 |
Bioorg Med Chem Lett 16: 4767-71 (2006)
Article DOI: 10.1016/j.bmcl.2006.06.086 BindingDB Entry DOI: 10.7270/Q2MC8ZN4 |
More data for this Ligand-Target Pair | |
Cytochrome P450 3A4
(Homo sapiens (Human)) | BDBM50191163
![PNG](/data/jpeg/tenK5019/BindingDB_50191163.png) (1-(2-(benzyloxy)-5-bromobenzyl)-5-methyl-1H-pyrazo...)Show InChI InChI=1S/C19H17BrN2O3/c1-13-9-17(19(23)24)21-22(13)11-15-10-16(20)7-8-18(15)25-12-14-5-3-2-4-6-14/h2-10H,11-12H2,1H3,(H,23,24) | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt UniProtKB/TrEMBL
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet ![](/images/AffyNet_logo.png)
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| n/a | n/a | >1.00E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
GlaxoSmithKline
Curated by ChEMBL
| Assay Description Inhibition of CYP450 3A4 |
Bioorg Med Chem Lett 16: 4767-71 (2006)
Article DOI: 10.1016/j.bmcl.2006.06.086 BindingDB Entry DOI: 10.7270/Q2MC8ZN4 |
More data for this Ligand-Target Pair | |
Prostaglandin E2 receptor EP1 subtype (EP1)
(Homo sapiens (Human)) | BDBM50191163
![PNG](/data/jpeg/tenK5019/BindingDB_50191163.png) (1-(2-(benzyloxy)-5-bromobenzyl)-5-methyl-1H-pyrazo...)Show InChI InChI=1S/C19H17BrN2O3/c1-13-9-17(19(23)24)21-22(13)11-15-10-16(20)7-8-18(15)25-12-14-5-3-2-4-6-14/h2-10H,11-12H2,1H3,(H,23,24) | KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet ![](/images/AffyNet_logo.png)
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| n/a | n/a | 6.30 | n/a | n/a | n/a | n/a | n/a | n/a |
GlaxoSmithKline
Curated by ChEMBL
| Assay Description Displacement of [3H]PGE2 from EP1 receptor |
Bioorg Med Chem Lett 18: 1592-7 (2008)
Article DOI: 10.1016/j.bmcl.2008.01.071 BindingDB Entry DOI: 10.7270/Q2N58NNN |
More data for this Ligand-Target Pair | |
Cytochrome P450 1A
(Homo sapiens (Human)) | BDBM50191163
![PNG](/data/jpeg/tenK5019/BindingDB_50191163.png) (1-(2-(benzyloxy)-5-bromobenzyl)-5-methyl-1H-pyrazo...)Show InChI InChI=1S/C19H17BrN2O3/c1-13-9-17(19(23)24)21-22(13)11-15-10-16(20)7-8-18(15)25-12-14-5-3-2-4-6-14/h2-10H,11-12H2,1H3,(H,23,24) | PDB MMDB
Reactome pathway KEGG
B.MOAD DrugBank GoogleScholar AffyNet ![](/images/AffyNet_logo.png)
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| n/a | n/a | 2.10E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
GlaxoSmithKline
Curated by ChEMBL
| Assay Description Inhibition of CYP450 1A2 |
Bioorg Med Chem Lett 16: 4767-71 (2006)
Article DOI: 10.1016/j.bmcl.2006.06.086 BindingDB Entry DOI: 10.7270/Q2MC8ZN4 |
More data for this Ligand-Target Pair | |
Cytochrome P450 2C9
(Homo sapiens (Human)) | BDBM50191163
![PNG](/data/jpeg/tenK5019/BindingDB_50191163.png) (1-(2-(benzyloxy)-5-bromobenzyl)-5-methyl-1H-pyrazo...)Show InChI InChI=1S/C19H17BrN2O3/c1-13-9-17(19(23)24)21-22(13)11-15-10-16(20)7-8-18(15)25-12-14-5-3-2-4-6-14/h2-10H,11-12H2,1H3,(H,23,24) | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt UniProtKB/TrEMBL
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet ![](/images/AffyNet_logo.png)
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| n/a | n/a | >1.00E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
GlaxoSmithKline
Curated by ChEMBL
| Assay Description Inhibition of CYP450 2C9 |
Bioorg Med Chem Lett 16: 4767-71 (2006)
Article DOI: 10.1016/j.bmcl.2006.06.086 BindingDB Entry DOI: 10.7270/Q2MC8ZN4 |
More data for this Ligand-Target Pair | |
Cytochrome P450 2D6
(Homo sapiens (Human)) | BDBM50191163
![PNG](/data/jpeg/tenK5019/BindingDB_50191163.png) (1-(2-(benzyloxy)-5-bromobenzyl)-5-methyl-1H-pyrazo...)Show InChI InChI=1S/C19H17BrN2O3/c1-13-9-17(19(23)24)21-22(13)11-15-10-16(20)7-8-18(15)25-12-14-5-3-2-4-6-14/h2-10H,11-12H2,1H3,(H,23,24) | PDB
UniProtKB/SwissProt UniProtKB/TrEMBL
GoogleScholar AffyNet ![](/images/AffyNet_logo.png)
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| n/a | n/a | >1.00E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
GlaxoSmithKline
Curated by ChEMBL
| Assay Description Inhibition of CYP450 2D6 |
Bioorg Med Chem Lett 16: 4767-71 (2006)
Article DOI: 10.1016/j.bmcl.2006.06.086 BindingDB Entry DOI: 10.7270/Q2MC8ZN4 |
More data for this Ligand-Target Pair | |